Novel Therapeutic Approach to Cardiovascular Disease from SENS Research Foundation Flagship Research Program Graduates from Laboratory to the Biotech World

MOUNTAIN VIEW, Calif., Nov. 14 (Korea Bizwire) — Underdog Pharmaceuticals, Inc. (Underdog), and SENS Research Foundation (SRF) today announced the launch of Underdog and the completion of its seed round, providing $3.95 million to promote Underdog’s development of disease-modifying treatments for atherosclerosis and other age-related diseases. SRF also announced two senior appointments. The Underdog round [...]